Table 5.

Acceptability for gene testing HBC/HBOC and HNPCC

No. of patients who were offered gene testing	203
No. of patients who declined gene testing	9
No. of patients with a deleterious mutation/mutation of probable significance, who declined treatment at the Institute after the initial diagnosis and registration in the hereditary cancer clinic	1/21
No. of patients with deleterious mutation/mutation of probable significance, who did not want to know the results, in spite of regular follow-up at the Institute	12/21
No. of patients with deleterious mutation/mutation of probable significance, who took the results	8/21
Number of patients who wanted predictive testing for their children/sibs	2/8